St. Jude and Partners Develop Data Platform Unifying Blood Cancer Genomics and Clinical Data

St. Jude Children's Research Hospital, the American Society for Hematology, and Munich Leukemia Laboratory have developed the ASH HematOmics Program (ASHOP), a data-sharing platform that integrates genomics, gene expression, and clinical information from nearly 6,000 blood cancer patients. The platform combines large pediatric and adult datasets with built-in analysis tools, creating one of the most comprehensive blood cancer data collections available to date. By uniting previously siloed genomic and clinical information, ASHOP aims to accelerate research discoveries and improve treatment outcomes for patients with hematologic malignancies.

Development of the ASH HematOmics Program (ASHOP) data platform

• ▪St. Jude Children's Research Hospital, the American Society for Hematology, and the Munich Leukemia Laboratory developed the ASH HematOmics Program (ASHOP) data-sharing platform.
• ▪The ASH HematOmics Program (ASHOP) unites genomics, gene expression and clinical information from nearly 6,000 patients with blood cancers.
• ▪The ASH HematOmics Program (ASHOP) includes built-in analysis tools.

Integration of comprehensive blood cancer datasets and analysis capabilities

• ▪The ASH HematOmics Program (ASHOP) integrates large pediatric and adult datasets.
• ▪The ASH HematOmics Program (ASHOP) provides one of the most comprehensive blood cancer data collections to date.

Perspective of St. Jude Children's Research Hospital researchers

• ▪Unifying genomic and clinical data in ASHOP removes barriers that previously slowed blood cancer research progress.
• ▪The ASH HematOmics Program (ASHOP) platform enables researchers to identify patterns across different blood cancer types more efficiently than previous methods.

1 source